{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:55:28Z","timestamp":1722300928059},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.2169\/internalmedicine.2570-18","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T22:03:43Z","timestamp":1568498623000},"page":"2703-2709","source":"Crossref","is-referenced-by-count":4,"title":["Simultaneous Development of Progressive Multifocal Leukoencephalopathy and Cryptococcal Meningitis during Methotrexate and Infliximab Treatment"],"prefix":"10.2169","volume":"58","author":[{"given":"Yasunobu","family":"Nosaki","sequence":"first","affiliation":[{"name":"Department of Neurology, Toyohashi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ohyama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toyohashi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toyohashi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toyohashi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[{"name":"Department of Virology 1, National Institute of Infectious Diseases, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushige","family":"Iwai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Toyohashi Municipal Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nakamichi K, Mizusawa H, Yamada M, et al. Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan. BMC Neurol 12: 121, 2012.","DOI":"10.1186\/1471-2377-12-121"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS. AIDS 23: 525-530, 2009.","DOI":"10.1097\/QAD.0b013e328322ffac"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Piccinni C, Sacripanti C, Poluzzi E, et al. Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. Eur J Clin Pharmacol 66: 199-206, 2010.","DOI":"10.1007\/s00228-009-0739-z"},{"key":"4","unstructured":"4. Pyrgos V, Seitz AE, Steiner CA, Prevots DR, Williamson PR. Epidemiology of cryptococcal meningitis in the US: 1997-2009. Plos One 8: 390-396, 2013."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sammut L, Wallis D, Holroyd C. Progressive multifocal leukoencephalopathy associated with infliximab. J R Coll Physicians Edinb 46: 163-165, 2016.","DOI":"10.4997\/JRCPE.2016.305"},{"key":"6","unstructured":"6. Qu J, Zhou T, Zhong C, Deng R, L\u00fc X. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. BMC Infect Dis 17: 51, 2017."},{"key":"7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1073274817729901","volume":"24","author":"C Bohra","year":"2017","unstructured":"7. Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control 24: 1-9, 2017.","journal-title":"Cancer Control","ISSN":"http:\/\/id.crossref.org\/issn\/1073-2748","issn-type":"print"},{"key":"8","unstructured":"8. Smolen JS, Landew\u00e9 R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76: 960-977, 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Maini RN, Feldmann M. How does infliximab work in rheumatoid arthritis? Arthritis Res 4: S22-S28, 2002.","DOI":"10.1186\/ar549"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ryschkewitsch CF, Jensen PN, Major EO. Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 57: 243-248, 2013.","DOI":"10.1016\/j.jcv.2013.03.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mathews T, Wisotzkey H, Moossy J. Multiple central nervous system infections in progressive multifocal leukoencephalopathy. Neurology 26: 9-14, 1976.","DOI":"10.1212\/WNL.26.1.9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Malas D, Weiss S. Progressive multifocal leukoencephalopathy and cryptococcal meningitis with systemic lupus erythematosus and thymoma. Ann Neurol 1: 188-191, 1977.","DOI":"10.1002\/ana.410010216"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Weitzman S, Kaufman S, Wolpow E, Hinton RC, Richardson EP Jr. Case report. Simultaneous fungal and viral infection of the central nervous system. Am J Med Sci 276: 127-132, 1978.","DOI":"10.1097\/00000441-197807000-00014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sarkis RA, Mays M, Isada C, Ahmed M. MRI findings in cryptococcal meningitis of the non-HIV population. Neurologist 19: 40-45, 2015.","DOI":"10.1097\/NRL.0000000000000000"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhong Y, Zhou Z, Fang X, Peng F, Zhang W. Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis. Eur J Clin Microbiol Infect Dis 36: 1367-1372, 2017.","DOI":"10.1007\/s10096-017-2941-8"},{"key":"16","unstructured":"16. Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. Eur J Neurol 19: 1060-1069, 2012."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Williamson EML, Berger JR. Diagnosis and treatment of progressive multifocal leukoencephalopathy associated with multiple sclerosis therapies. Neurotherapeutics 14: 961-973, 2017.","DOI":"10.1007\/s13311-017-0570-7"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Baughman RP, Lower EE. Fungal infections as a complication of therapy for sarcoidosis. QJM 98: 451-456, 2005.","DOI":"10.1093\/qjmed\/hci073"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kluger N, Poirier P, Guilpain P, Baixench MT, Cohen P, Paugam A. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Beh\u00e7et's disease. Int J Infect Dis 13: e325, 2009.","DOI":"10.1016\/j.ijid.2008.11.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Trillos RF, Fern\u00e1ndez-\u00c1vila DG, D\u00edaz MC, Guti\u00e9rrez JM. Cryptococcal meningoencephalitis in a patient with rheumatoid arthritis treated with methotrexate and prednisone. Reumatol Clin 10: 346-347, 2014.","DOI":"10.1016\/j.reumae.2014.02.004"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vasant DH, Limdi JK, Borg-Bartolo SP, Bonington A, George R. Posterior reversible encephalopathy syndrome and fatal cryptococcal meningitis after immunosuppression in a patient with elderly onset inflammatory bowel disease. ACG Case Rep J 3: e98, 2016.","DOI":"10.14309\/crj.2016.71"},{"key":"22","unstructured":"22. Zaheer F, Berger JR. Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps. Ther Adv Drug Saf 3: 227-239, 2012."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Calabrese LH, Molloy E, Berger J. Sorting out the risks in progressive multifocal leukoencephalopathy. Nat Rev Rheumatol 11: 119-123, 2015.","DOI":"10.1038\/nrrheum.2014.167"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Clavel G, Moulignier A, Semerano L. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments. Joint Bone Spine 84: 671-675, 2017.","DOI":"10.1016\/j.jbspin.2017.03.002"},{"key":"25","unstructured":"25. Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum 64: 3043-3051, 2012."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kumar D, Bouldin TW, Berger RG. A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab. Arthritis Rheum 62: 3191-3195, 2010.","DOI":"10.1002\/art.27687"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Keene DL, Legare C, Taylor E, Gallivan J, Cawthorn GM, Vu D. Monoclonal antibodies and progressive multifocal leukoencephalopathy. Can J Neurol Sci 38: 565-571, 2011.","DOI":"10.1017\/S0317167100012105"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Solomon AJ, Spain RI, Kruer MC, Bourdette D. Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Mult Scler 17: 1472-1487, 2011.","DOI":"10.1177\/1352458511412996"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kishida S, Tanaka K. Mefloquine treatment in a patient suffering from progressive multifocal leukoencephalopathy after umbilical cord blood transplant. Intern Med 49: 2509-2513, 2010.","DOI":"10.2169\/internalmedicine.49.3227"},{"key":"30","unstructured":"30. Sano Y, Nakano Y, Omoto M, et al. Rituximab-associated progressive multifocal leukoencephalopathy derived from non-Hodgkin lymphoma: neuropathological findings and results of mefloquine treatment. Intern Med 54: 965-970, 2015."},{"key":"31","unstructured":"31. Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M; Progressive Multifocal Leukeoncephalopathy Consortium. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord 8: 255-273, 2015."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lima MA, Bernal-Cano F, Clifford DB, Gandhi RT, Koralnik IJ. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 81: 1288-1291, 2010.","DOI":"10.1136\/jnnp.2009.179002"},{"key":"33","unstructured":"33. Post MJ, Thurnher MM, Clifford DB, et al. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. AJNR Am J Neuroradiol 34: 1297-1307, 2013."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Nakamichi K, Kishida S, Tanaka K, et al. Sequential changes in the non-coding control region sequences of JC polyomaviruses from the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Arch Virol 158: 639-650, 2013.","DOI":"10.1007\/s00705-012-1532-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2570-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:38:58Z","timestamp":1569037138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2570-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,15]]},"references-count":34,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2570-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,15]]}}}